QuidelOrtho Corporation QDEL

QDEL Company Overview

QuidelOrtho Corporation is a U.S.-based diagnostics company that develops and manufactures in vitro diagnostic technologies used in clinical laboratories, hospitals, physician offices, retail settings, and point-of-care environments. The company operates within the broader healthcare diagnostics and medical technology industries, with a focus on immunoassay, molecular diagnostics, clinical chemistry, transfusion medicine, and rapid diagnostic testing. QuidelOrtho was formed through the 2022 combination of Quidel Corporation and Ortho Clinical Diagnostics, creating a diversified diagnostics platform with broad global reach and an expanded product portfolio.

The company’s primary revenue drivers include diagnostic instruments, consumables, reagents, and testing services across infectious disease, blood typing, donor screening, and laboratory automation markets. Key product families include the Sofia, Savanna, and QuickVue diagnostic platforms from the former Quidel business, alongside Vitros systems and transfusion medicine offerings from Ortho Clinical Diagnostics. QuidelOrtho serves hospitals, reference laboratories, blood banks, public health agencies, and decentralized care providers. Its strategic positioning is supported by a large installed instrument base, recurring consumables revenue, broad regulatory clearances, and established relationships with healthcare systems worldwide.